Trial intelligence / Profile preview

Pain relief management by Kalinox 170 bar for short-time painful procedures in pediatric patients

2006-001284-33Phase 4Active

Sponsor
Air Liquide
Start
May 2006
Modality
Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, single-arm trial of nitrous oxide + oxygen, sponsored by Air Liquide. Primary endpoint: Pain relief self-assessment during invasive procedures. Started May 2006; status: active.

02

Drugs

nitrous oxide + oxygen

Beyond the preview

Go deeper on 2006-001284-33.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-001284-33.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call